Clovis Oncology Inc. (CLVS) Dropped -6.1% or -1.99 To Price $30.65 On Tuesday


Clovis Oncology Inc. (CLVS) dropped -6.1% or -1.99 to $30.65. It is about 1.21 million shares traded, which is 165.37% compare to the average total volume 731780. The market cap of CLVS is $1.61 billion. The year to date change is -56.68%. The 52 week price range is from $29.74 to $86.26. Price of CLVS have changed 1.40% during last week. It have changed -7.14% over last month, -28.36% over last 3 months, -42.13% over last 6 months and -57.03% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 37.74. It is 23.13% above current price. The 200-day Moving Averages for CLVS is 50.14. It is 63.59% above current price. The 52-week High is 86.26. It is 181.44% from the current price. The 52-week Low is 29.74. It is -2.97% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLVS is 7.29 on 2018-08-31. Short % to float is 16.16%. There are some statistics of CLVS. It is has market cap $1.61 billion. The share outstanding is 52.65 million. The average volume is 731780. The revenue is 16.81M. The gross profit is 13.41M. The percent of top 15 Institution holding is 90.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -87.79%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -31.73%.


Tags:

Share this post